Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
1301 Treatment with a novel hexavalent OX40 agonist enhan... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
1301 Treatment with a novel hexavalent OX40 agonist enhances activation of circulating T cells to favor anti-tumor immunity
0
Authors
Nisha Holay
5 more
Nisha Holay
•
Melissa Kasiewicz
3 more
•
William Redmond
Published
November 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Regular and Young Investigator Award Abstracts
Topics
Chemistry
Cancer Oncology
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1136/jitc-2024-sitc2024.1301
